Stock Option Plans (Q2) (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2018

Dec. 31, 2017

EMPLOYEE AND DIRECTOR BENEFITS [Abstract]

Stock-based Compensation Recognized as Compensation Expense

Total stock-based compensation recognized as compensation expense on our consolidated statement of income for the three and six months ended June 30, 2018 and 2017 is as follows:

	Three months ended June 30, 2018		Three months ended June 30, 2017
Dollars in thousands
Option Grants	$	-	$	9
Restricted Stock Grants		-		-
Total compensation expense	$	-	$	9

	Six months ended June 30, 2018		Six months ended June 30, 2017
Dollars in thousands
Option Grants	$	1	$	18
Restricted Stock Grants		-		-
Total compensation expense	$	1	$	18

Total stock-based compensation recognized as compensation expense on our consolidated statement of income is as follows:

	December 31, 2017		December 31, 2016
Dollars in thousands
Option Grants	$	24	$	49
Restricted Stock Grants		-		11
Total Compensation Expense	$	24	$	60

Summary of Option Activity under Stock Option Plans

A summary of option activity under the stock option plans as of June 30, 2018 and changes during the period ended June 30, 2018 is presented below:

	Shares			Weighted Average Exercise Price		Weighted Average  Remaining Contractual Term	Aggregate  Intrinsic Value
Outstanding, December 31, 2017		151,173		$	4.54	5.27 years
Exercised		(3,107	)		4.84
Expired		(12,000	)		12.22
Forfeited		-			-
Granted		-			-
Outstanding, June 30, 2018		136,066		$	3.85	5.19 years	$	597,308
Exercisable, June 30, 2018		136,066		$	3.85		$	597,308

A summary of option activity under the stock option plans as of December 31, 2017 and changes during the year ended December 31, 2017 is presented below:

	Shares			Weighted  Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding, December 31, 2016		184,892		$	6.67	5.40 years
Exercised		(3,738	)	$	3.36
Expired		(28,981	)	$	18.31
Forfeited		(1,000	)	$	4.91
Granted		-		$	-
Outstanding, December 31, 2017		151,173		$	4.54	5.27 years	$	790,199
Exercisable, December 31, 2017		150,215		$	4.53		$	786,232

Summary of Restricted Stock Activity

A summary of restricted stock activity during the three and six months ended June 30, 2017 is presented below:

	Three Months Ended June 30, 2017				Six Months Ended June 30, 2017
	Non-Vested Restricted Stock Outstanding		Weighted Average Grant Date Fair Value		Non-Vested Restricted Stock Outstanding			Weighted Average Grant Date Fair Value
Beginning balance outstanding		-		-		3,334		$	3.31
Granted		-				-
Vested		-				(3,334	)
Ending balance outstanding		-		-		-			-

A summary of restricted stock activity during the twelve months ended December 31, 2017 and 2016 is presented below:

	December 31, 2017					December 31, 2016
	Non-Vested Restricted Stock  Outstanding			Weighted Average Grant Date  Fair Value		Non-Vested Restricted Stock Outstanding			Weighted Average  Grant Date  Fair Value
Beginning balance outstanding		3,334		$	3.31		6,667		$	3.31
Granted		-					-
Vested		(3,334	)				(3,333	)
Ending balance outstanding		-			-		3,334		$	3.31